It seems that a series of one day conferences, organised by the Animal Health agency for vets and animal health inspectors involved in fighting bovine TB, haven't gone down as well as hoped.
According to a report in yesterday's Daily Telegraph, many in the audience were angered when they were asked to spend up to an hour playing a game involving bongo drums.
Incredibly, a spokesman for Animal Health apparently told the Daily Telegraph that: "It was meant to emphasise how people working together can build up a rhythm."
Petplan is calling for nominations for this year's 'Petplan Pet Insurance Advisor Award'.
The award is to recognise the hard work and dedication that Pet Insurance Advisors (PIAs) do to highlight the importance of insurance to pet owners so that they are protected financially. You can nominate a PIA at your practice by visiting www.petplan.co.uk/pia. The winner will receive a new laptop and their practice will receive £100 in vouchers.
Petplan Marketing Manager Alison Andrew said: "At Petplan we are proud to recognise the dedication and hard work that Pet Insurance Advisors put in to give their customers informed and up-to-date advice. So please get your nominations in!"
Nominations close on 3rd September and the nominees will be judged by industry professionals. The winner will be announced at the annual BVNA Congress on 9th October.
BCF Technology has announced that it now has the 9020HF ultralight and the 10040HF ultra orange x-ray generators available in blue.
Jason Rogers of BCF said: "Our range of generators aims to meet the needs of any size of veterinary practice. The new blue generators will compliment our existing range. The bright blue colour means they will be eye-catching in the field, meaning you wont leave them behind!"
What next? The BCF Spring Collection - a range of ultrasound scanners in pale, neutral shades guaranteed not to clash with your overalls?
To find out more about BCF Technology's range of x-ray equipment and generators visit http://www.bcftechnology.com/
The Animal Medicines Training Regulatory Authority (AMTRA) is launching its new Continuous Professional Development (CPD) scheme today, designed to ensure that the Authority's registered Suitably Qualified Persons (SQPs) keep up to date with the latest animal medicines information.
In order to maintain their SQP status, every SQP will have to achieve a minimum number of CPD points during each AMTRA CPD period, running for two years from July to June. However, in the initial stages of the scheme, this first period will run for 33 months, from October 2008 to June 2011, allowing AMTRA to fine tune the system if required and give its SQPs time to get used to the new structure.
During these CPD periods, SQPs are required to obtain a minimum number of CPD points depending on their SQP type:
SQP Type: Modules; VPS medicines supplied; CPD PointsR-SQP: FAM+EQM+CAM; All VPS Medicines; 70 pointsG-SQP: FAM+EQM; VPS-farm animals and equines only; 50 pointsK-SQP: FAM+CAM; VPS-farm and companion animals only; 50 pointsE-SQP: EQM+CAM; VPS-equines and companion animals only; 50 pointsL-SQP: FAM; VPS-farm animals only; 30 pointsJ-SQP: EQM; VPS-equines only; 30 pointsC-SQP: CAM; VPS-companion animals only; 30 points
(FAM - Farm Animal Module, EQM - Equine Module, CAM - Companion Animal Module)
In essence, this means that 20 points are required per animal group, plus a further 10 points. Dr Roger Dawson, Secretary of AMTRA comments, "There is no maximum number of CPD points that SQPs can accumulate and we will be encouraging them to gain the benefit of as much CPD as they can."
Those SQPs who do not achieve the minimum number of CPD points by the end of the period will not be eligible to renew their status for the following year. However, such SQPs will have the option of sitting an examination before the end of that CPD period in order to maintain their SQP status and eligible be to renew for the next year.
SQPs will have a range of avenues through which to gain CPD points, ranging from four types of AMTRA-accredited CPD Events, to online study and personal study. With CPD Events and online studies, accreditation and points will be awarded by the AMTRA CPD Accreditation Panel. With personal study, AMTRA accepts a degree of self-certification of this form of CPD, however the points gained in this way are limited to a relatively small proportion of the minimum required in a CPD period.
Throughout a CPD period, all SQPs are required to attend at least ONE CPD Event. These events will comprise a range of modules that will be assessed for coverage, of relevant topics ranging from legislation, regulations and prevalence & effects of parasites and pathogens, to control of disease management, resistance, warnings and SARS.
Dr Dawson says, "The new CPD scheme has the necessary flexibility to allow SQPs to gain the required CPD points via a number of routes, from accredited CPD events and online study to personal study. Furthermore, the structure of the scheme ensures that their studies will be properly assessed to ensure they have gained the necessary knowledge to secure their CPD points."
Boehringer Ingelheim Vetmedica has announced that it will be launching Bovela, a new viral diarrhoea (BVD) vaccine, to farmers during April 2015.
Allan Henderson from Boehringer said: "BVD remains the most common viral disease affecting cattle throughout Europe, despite vaccines being available for over 15 years. We asked farmers why this was the case and, without exception, they remarked that current vaccine protocols are unwieldy, requiring precise timings making them hard to follow.
"Bovela is a unique one-shot vaccine that can be used in cattle from three months of age and also whether pregnant or not. Other, currently available vaccines require a two-dose primary course with boosters annually or even every six months thereafter."
BVD is spread within herds and to new herds through the presence of persistently infected (PI) animals. PIs can look relatively healthy and show no outward signs of infection but, as they were exposed to the virus as a foetus, have become virus carriers. If they are born alive, they will shed virus consistently throughout their lives so perpetuating the cycle of infection.
Alan said: "The foetal control delivered by Bovela gives absolute confidence that cows will not produce PIs. This, alongside the drastically improved convenience will undoubtedly make Bovela the natural choice for many farmers, both on beef and dairy farms."
According to Boehringer, around 60% of cattle in the EU test positive for exposure to the BVD virus and, although BVD type 1 is currently the most common form, outbreaks of BVD type 2, were confirmed in 2013 and 2014 in Belgium, Germany and The Netherlands. BVD type 2 is generally a more serious disease, with high levels of mortality and while the virus has been identified in UK, it has not yet been identified as the cause of serious outbreaks of disease in cattle.
Alan said: "Bovela is the first and only vaccine in UK which has been proven to protect cattle from BVD type 1 and 2. It has been in development for 17 years and, gained a marketing authorisation following assessment of an unprecedented quantity of data generated in both beef and dairy herds.
"Work has looked at the efficacy of Bovela in preventing the production of PI calves and against type 1 and 2 BVD as well as confirming its efficacy in young calves as young as three months of age as their natural maternal protection wears off. Trials also confirmed vaccine safety generally and during various stages of pregnancy. We do not believe that any other BVD vaccine has been tested as rigorously."
The nine-page booklet is being distributed electronically to all BEVA members, together with a guide on spotting some of the warning signs horses may display, written by equine veterinary surgeon and behaviourist Gemma Pearson.
A report commissioned by the BEVA in 2013 indicated that an equine vet could expect to sustain between seven and eight work-related injuries that impeded them from practicing, during a 30-year working life.
Data available from the Health and Safety Executive suggests that this is a very high number of injuries compared to other civilian occupations, including those working in the construction industry, prison service and the fire brigade.
The new guide has been produced ‘by horse vets for horse vets’ with BEVA members contributing their views, experiences and suggestions to early drafts.
It provides information for those handling and involved with equine veterinary care; to make workers consider the steps that they can take to make their activities as safe as reasonably possible by assessing a situation and implementing measures to limit the risk that vets and others are exposed to.
The guide also aims to challenge prevailing attitudes and culture. It outlines how to make ‘on the spot’ or ‘mental’ risk assessments and when to stop if a procedure becomes unsafe.
The guide is accompanied by an illustrated leaflet Signs of Increased Arousal Combined with a Negative Effective State. Written by Gemma Pearson, BVMS Cert AVP (EM) MRCVS who specialises in equine behaviour and learning theory, it explains signs of increased arousal including facial expressions, stance, movement and response.
David Mountford, CEO of BEVA said: "The new guidelines have been carefully developed to ensure that they are as pertinent, pragmatic and helpful as possible for vets in practice. Hopefully they will help to make the equine veterinary workplace a little safer."
The new guides can be downloaded at: https://www.beva.org.uk/workplacesafety
The association says the qualification will help vets conduct clinical research relating to their work - in particular vets working in practice. It is aimed at people who already have any accredited postgraduate certificate (60 credits at Level 7) relevant to some aspect of veterinary medicine or surgery and are keen to develop a deeper understanding of their research topic.
The Masters starts with online study into the principles of clinical research, which students then apply to their own research project, based on a further 1,200 study hours that could be flexibly achieved in two years of part-time study or up to five years, depending on the project type and an individual’s availability.
Lucie Goodwin, BSAVA Head of Education (pictured right), said: "For those vets who have already completed a postgraduate certificate it is an opportunity to develop their skills further, partake in research and collect valuable data from the field. So much of the published data in veterinary journals is based upon a referral population and this may not necessarily reflect what truly happens in clinical practice."
She added: "The BSAVA Masters is designed to appeal to vets who want to undertake research alongside their job role, without having to commit to a full-time programme of study."
Students will be allocated a ‘matched’ supervisor to provide project advice and guidance, plus the BSAVA team will be on hand to ensure ongoing support and encouragement.
Johanna Forsyth, senior veterinary technical manager with the diagnostic laboratory Avacta Animal Health, joined the Masters programme when it launched in 2016. She said: "The thing that has given me the most satisfaction from taking part in this programme is the way my views have changed. I look at things I wrote a little while back and think: 'Did I really say that?'. You become so absorbed in the project that you don’t notice how your understanding of the topic has grown. It’s so subtle, we haven’t been force-fed anything - it’s just like osmosis."
For more information, please contact masters@bsava.com or visit the website https://www.bsava.com/Education/Masters
The BSAVA Library Collection, which is freely available until the end of June 2020, includes resources relating to total intravenous anaesthesia (TIVA) and anaesthetic monitoring in addition to a new guidance document on the administration of anaesthetics during the pandemic, which has been endorsed by the Association of Veterinary Anaesthetists (AVA).
Kerry Woodhouse, author of the guidance document, said: “In line with RCVS recommendations to promote safe practice and social distancing, anaesthesia for routine procedures should be stopped during the current restrictions relating to the COVID-19 pandemic. There will however remain a need for anaesthetics for emergency and urgent procedures on welfare grounds. This guidance document provides practical information on administering anaesthesia while conserving oxygen supplies."
BSAVA President, Sue Paterson added: “The potential prioritisation of oxygen cylinders into human medicines means that we must be ready and able to revert back to using some more basic anaesthetic techniques. BSAVA is pleased to be able to support the profession during these challenging times through the provision of up-to-date guidance and resources to address these concerns.”
The new Anaesthesia Resources collection can be found here: https://www.bsavalibrary.com/content/update
The Association is also reassuring the profession that there is no indication of a shortage of medical gases.
In preparation for an escalation of coronavirus cases, BOC has been building stocks of medical gases to ensure its supply chain is in the best position to respond to customer requirements.
BOC has also implemented a ‘Full for Empty’ supply of all medical cylinder gases and customers with medical oxygen are being encouraged to manage their cylinders in an effective manner and ensure that empty cylinders are available promptly for collection. The company has also increased the frequency of deliveries and collections to help with cylinder turnover.
Customers are being asked to be vigilant and ensure that medical gas cylinders are kept as secure as possible to deter potential misuse or theft.
BSAVA understands that if a practice is closed for the foreseeable future, BOC will collect cylinders free of charge.
For further information, call BOC’s Customer Information Centre on 0800 111 333 or visit https://www.boconline.co.uk/shop/en/uk/customer-information
For more BSAVA resources relating to coronavirus, visit https://www.bsava.com/adviceforCOVID19
The RCVS Disciplinary Committee has dismissed an application to be restored to the Register of Veterinary Surgeons from former Wirral-based vet Ian Beveridge.
In May 2013 the Committee had asked the Registrar to remove Mr Beveridge from the Register following a four-day hearing in which he was found guilty of serious professional misconduct after finding that he had treated clients badly, kept inadequate clinical records, was dishonest in his dealings with the RCVS and that animals in his care were placed at risk.
In June 2013 Mr Beveridge, who was not present or represented at the original hearing, then appealed the decision. The appeal was withdrawn in May 2014 which was when Mr Beveridge was formally removed from the Register.
Then, in April 2015, Mr Beveridge applied to be restored to the Register. The Disciplinary Committee met to consider his application in June 2015, however, this hearing was adjourned after new evidence was served to the Committee concerning allegations that Mr Beveridge had ordered prescription-only veterinary medicines when he was not authorised to do so. He was subsequently interviewed by police who took no further action.
In deciding whether Mr Beveridge was fit to be restored to the Register, the Committee heard evidence in regards to the circumstances in which the prescription-only drugs were ordered using his account and delivered to his former practice address which had been taken over by Medivet after he sold the premises to the company.
During the course of the hearing, Mr Beveridge admitted that his account had been used to buy the drugs, but that a part-time member of his staff, who was neither a veterinary surgeon nor a veterinary nurse, had done so without his prior knowledge or approval.
In relation to this evidence Ian Green, chairing and speaking on behalf of the Committee, said: "The Committee takes the view that the unauthorised use of a veterinary surgeon’s drugs account for which he carries the ultimate responsibility is a very serious matter and, of itself, demonstrates that the applicant has at best a cavalier attitude to his work which of itself means that he remains unfit to be on the Register.
"This attitude is further demonstrated by the fact that, even after the first orders were placed in late April and early May 2014, the applicant did not seek clarification from the College of his status following the withdrawal of his appeal against the original Committee’s findings."
In addition to this, the Committee also considered the seriousness of his original failings, the fact that Mr Beveridge’s acceptance of these failings was ‘qualified’, that he had been off the Register for 20 months and the fact that his efforts in terms of continuing professional development had been inadequate and not focused on those areas in need of improvement, among other factors. In mitigation it did consider that Mr Beveridge had demonstrated genuine remorse about previous actions and noted a petition and a large number of letters in support of him from former clients of his practice.
However, the Committee felt that this did not detract from the seriousness of the original failings and, in conjunction with the subsequent unauthorised ordering of veterinary drugs, that the application for restoration must be dismissed.
The study titled “Electrolyte measurements differ between point-of-care and reference analysers in dogs with hypoadrenocorticism” investigated the performance of two point-of-care analysers (IDEXX Catalyst Dx and IDEXX VetStat) against a reference laboratory method for the measurement of blood sodium, potassium and chloride concentrations, as well as sodium-to-potassium ratios, in dogs diagnosed with and treated for hypoadrenocorticism.
Forty-eight dogs with hypoadrenocorticism were enrolled into a prospective cross-sectional study at the University of Glasgow. In total, 329 paired samples were measured on the Catalyst analyser and by the reference laboratory method called an ion selective electrode (ISE), while another 72 paired samples were tested on both the VetStat analyser and by ISE. The clinical effects of any difference in the electrolyte results were investigated.
Sam Fowlie, corresponding author for the paper, said: “Our results indicate that the sodium, potassium and therefore the sodium-to-potassium ratios, as well as the chloride concentrations measured by the Catalyst and VetStat analysers may not be used interchangeably with those from a reference laboratory analyser using an indirect ISE method. Both analysers tended to give higher results than the reference method for all analytes, except for potassium when measured on the VetStat.”
The clinical relevance of the disagreement between these methods was investigated by assessing how often the point-of-care analysers produced results which fell outside their reference range when the ISE method found them to be within reference and vice versa. For the Catalyst, there were 21 cases (6%) with discordant sodium results, 27 cases (8%) with discordant potassium results and 46 cases (14%) with discordant chloride results. The VetStat, meanwhile produced results which disagreed with the ISE method in 19 cases (26%) for sodium, 3 cases (4%) for potassium measurement and 9 cases (13%) for chloride analysis.
Nicola Di Girolamo, Editor of JSAP added: “This study reveals significant systematic differences (“bias”) between the three analysers in this study. Comparing numerical results from different analytical methods – be they point-of-care or reference laboratories – can be dangerous for patients. Clinicians should always use method specific thresholds and, if these are not available (for example the sodium-to-potassium ratios on some analysers), then they should exercise greater caution in their interpretation.”
The full article can be found in the October issue of the Journal of Small Animal Practice and be read online here, open access: https://onlinelibrary.wiley.com/doi/10.1111/jsap.13205.
Reference
Photo: Ian Ramsey
Sophia Salmon MRCVS from Central CPD said: "All of the major corporate chains in the UK now deliver a significant proportion of their clinical and non-clinical staff training via online learning platforms. These systems form an important part of professional development, training standardisation and even performance evaluation.
"However, learning platforms can be expensive to procure and develop, as well as being time-consuming to maintain, and therefore may not be viable for smaller businesses."
Central CPD has used its experience providing online learning to several of the UK’s major corporate veterinary groups to create 'Central CPD On-Demand', which features over 1500 clinical and non-clinical CPD videos for vets, nurses, managers and receptionists.
There's a new practice subscription package which, developed with whole-team learning in mind, costs £2000 per year for up to twenty people (veterinary surgeons, nurses or management staff).
Central CPD says the new package allows individuals and practices to set their own learning plan for the year, and for mentors to build and supervise training programmes for other staff members.
Practices can add their own content, such as policy documents, in order to assist with the delivery of compulsory elements of staff training.
Central CPD says its service is a fraction of the cost of procuring and populating an off-the-shelf learning platform, and the company is staffed by vets and vet nurses who are available to provide one-to-one advice and support to help practices set up their team’s platform and get the most out of the system.
For more information, visit: https://centralcpd.co.uk/
For the research, Which? conducted an online poll of 1,009 pet owners who had had an issue with their vet in the past two years.
It also conducted qualitative interviews with 14 owners who had complained.
The most common reasons for complaint were:
Of the 1009 pet owners who had experienced some kind of problem with their vet, 57% did NOT make a complaint, 33% because they did not want to fall out with their vet.
Pet owners who wish to complain about veterinary services have three options: to complain directly to their practice, to use the voluntary Vet Client Mediation Service (VCMS), or to raise a 'concern' with the RCVS.
The Which? report found that of those who did complain to their practice, 35% were not happy with the outcome and 31% with the way it was handled.
Which? found that although the VCMS reported a high resolution rate of 84% in 2022-23, its interviewees had found it a bit hit or miss.
Finally, Which? found the process of complaining to the regulator flawed by the fact that the threshold for the College to progress a 'concern' is set so high, because College has no jurisdiction at a practice level, and because it has no sanctions to use in enforcing consumer law.
The report recommends that:
Full report: https://www.which.co.uk/policy-and-insight/article/complaints-and-redress-in-veterinary-services-a5z611X9tZzf
CommentI loved the regal response from the RCVS to The Guardian about the case studies in the Which? report: “the facts presented in the case studies do not completely align with those reported to us”.
That aside, surely the big issue here is not so much that consumers have little way to complain effectively.
That is important, of course, but isn't it more important to consider what they are complaining about, which in the main is MONEY.
Driven by the advances in veterinary medicine, the innate desire of vets to provide the best possible care, anthropomorphising pet owners saying they want 'the best' for their fur baby (without necessarily having the wherewithal), corporatisation and society's changing expectations about working conditions, prices have been going up at a rate far outstripping inflation.
Increasing prices have of course been accompanied by an increase the standards of care and the range of clinical equipment.
But the question everyone must ask is at what point the cost of veterinary care for a dog outstrips the benefits of owning one?
These complaints are the canary in the coalmine.
The Veterinary Development Council (VDC) is conducting a survey to investigate the role of paraprofessionals and technicians in veterinary practice, and is asking vets in large animal, equine, and mixed practices to complete a short survey.
The VDC says that information from the survey will help inform discussions on the regulation of technicians.
The survey will take between 5 and 10 minutes to complete and can be found on the BVA website at www.bva.co.uk/vdc. The BVA has also emailed the survey directly to practices.
The survey has been devised by the VDC working group looking at the role of the veterinary-led team, chaired by BVA Past President Professor Bill Reilly. This is one of three working groups that will report to the VDC:
Professor Reilly said: "The relationship between veterinary surgeons and technicians is vital but it varies from practice to practice.
"The working group on the role of the veterinary-led team aims to take a snapshot of how services, such as artificial insemination and foot trimming, are currently delivered, and gauge how veterinary surgeons feel about other services being delivered by non-veterinarians in the future.
"I hope veterinary surgeons in large, mixed and equine practice will take 10 minutes to complete our survey to help us map the current use of technicians in veterinary practice and help shape our future discussions."
The webinars will take place every Wednesday at 7pm in May.
David Bardell is a European and Royal College of Veterinary Surgeons Specialist in Veterinary Anaesthesia and Analgesia and will be hosting the first two sessions covering equine pain management for colic and orthopaedic cases respectively.
The 5th May webinar will cover how to recognise and understand the pathology of visceral pain, physical and pharmacological methods of analgesia and dealing with violent or difficult colic cases.
The second webinar on the following Wednesday, will look at how to recognise and quantify pain, the use of pain scales, analgesic medication and techniques.
The other two sessions of the series will be led by Dr. Andy Fiske-Jackson, Deputy Head of RVC Equine and Senior Lecturer in Equine Surgery at the Royal Veterinary College. He'll be running case-based sessions looking at the good, bad and ugly of digital flexor tendon sheath cases and unravelling the diagnosis and treatment of navicular syndrome, the associated biomechanics and treatment options respectively.
Emma Jennings, Equine Brand Manager at Dechra (pictured right) said: “The broad scope of illnesses and conditions facing those specialising in equine care means that it’s important to delve deeper into some key issues, which is what this series of webinars will do.
“We hope the expertise of David Bardell and Dr. Andy Fiske-Jackson will be of key interest to veterinary professionals across the country and would urge anyone interested to register for the sessions throughout May.”
To register for the free webinars, visit www.dechra.co.uk/events.
Linda gave her address at the Royal Institute of British Architects, venue for the RCVS Annual General Meeting last Friday.
Linda, an equine vet and director of the Wiltshire-based George Veterinary Group, said: “A Royal College and a regulator – it’s a challenge but this combined role is also an opportunity for us.
“In the time I’ve served the RCVS, I’ve definitely learnt some of what it takes to fulfil these roles under the remit of both the Veterinary Surgeons Act and our Royal Charter; to think not just from personal perspective and experience, and also to try to look beyond the needs of the profession today and consider what tomorrow might bring.
“Vets are not just one thing.
"The roles we fill in our working lives are many and varied, and I would argue that the MRCVS is the best placed arbiter of animal health and welfare.
"As such, keeping the MRCVS at the heart of decision-making around how veterinary care and services are provided is essential both to safeguard animal health and welfare and also to retain public trust in our work.
“Cultivating trust is a big part of what many of us do, day in and day out – trust in us from within our teams, from our clients and perhaps even from our patients.
“The RCVS with its two hats does a tough job for both the professions and the public.
"In many cases, the interests of the professions and the public align and there is no conflict.
"Of course, as a regulator where the interests don’t align, the RCVS regulates in the wider public interest and this, too, is a positive for us as a profession.
“Working in a regulated environment is a strength for us.
"The landscape in which we work has changed and the regulatory environment needs to change too. Now we are the other side of the general election, work can continue on legislative reform seeking parliamentary time for a new Veterinary Surgeons Act.”
As the 13th female President of the RCVS, Linda will lead an Officer Team comprising the now Senior Vice-President Dr Sue Paterson FRCVS, Junior Vice-President Professor Tim Parkin FRCVS and Treasurer Dr Tshidi Gardiner MRCVS as well as VN Council Chair Belinda Andrews-Jones RVN, who attends Officer Team meetings as an observer.
The project was 'highly commended' at the RCVS Knowledge 2024 awards.
The CVS clinical improvement project found that a major barrier to conducting ultrasound scans was a lack of confidence - both in using equipment and interpreting images.
A recent Canadian industry study has also reviewed barriers, citing a lack of equipment, training and skills as root causes1.
The ultrasound project aimed to review practice equipment, improve clinician case identification, increase clinical skills and confidence, and recommend ultrasound in all appropriate cases.
The company put together resources for vets and nurses designed to help improve ultrasound scan rates, including clinical guidelines, webinars for how to approach cases, and machine guides.
CVS then held training sessions which for vets focussed on case identification and improving diagnostic skills, and for vet nurses looked at how to use ultrasound equipment and conduct scans.
An audit of each participating practices’ ultrasound scan rates was conducted at the start of the project. Results were then shared with each practice every month.
Twelve months after launch, data shows that the number of ultrasound scans has increased by 3,675.
Anecdotal evidence has also shown that colleague confidence and practice team culture has improved as a result of the project.
Dr Victoria Woods, Regional Clinical Lead at CVS responsible for the ultrasound clinical improvement project, said: “It’s fantastic to see the benefits increased ultrasonography is already bringing to our practices on this project – especially as a result of upskilling our nurses.
"I am certain that this will help contribute towards them providing some of the best clinical diagnosis and care in our profession.”
Following the success of the project in its first year, the project is now being developed to focus on echocardiograph and is being undertaken in 52 CVS primary care practices in year two.
Liz set up vetsnet to bring together all the wellbeing, leadership and management tools being created by individuals, groups and veterinary organisations in one place, and then to curate, streamline and signpost resources to increase accessibility and use by everyone in the profession.
The Aviva scheme is open to anyone and offers the chance to get funding for an important cause within a community. If successful in its bid, Liz says it will allow Vetsnet to rebrand more clearly as a resource hub, increase ease of use and add user ratings, which in turn will help users to find the help they need when they need it.
Liz said: "I setup Vetsnet to meet needs experienced personally in practice life. Great work is being done to address the mental health and organizational issues within the profession, I wanted to curate, signpost and increase accessibility to the growing wealth of resources for all involved in the provision of veterinary services, to make it a happier profession."
Voting closes on 21st November. To add your support to the bid, go to https://community-fund.aviva.co.uk/voting/project/view/17-1093, register, opt out of mailing options and cast up to 10 votes for a single or multiple projects. Those with the most votes will be judged and finalists announced in the new year.
In his new role, Ian will guide the development of interventions, strategies, process changes and campaigns to improve responsible pharmaceutical usage across Mars Veterinary Health’s 2,500+ global veterinary clinics.
Ian was previously Head of Internal Medicine at Hertfordshire-based Davies Veterinary Specialists and antimicrobial resistance (AMR) subject matter expert on the clinical board of Linnaeus.
Mars says that this new role is one of several actions it is taking to promote pharmaceutical stewardship and combat antimicrobial resistance, include the implementation of a formal responsible pharmaceutical stewardship programme across all its veterinary clinics globally during the next several years.
Ian said: “As one of the leading providers of veterinary care in the world, we have a unique opportunity – and responsibility – to lead the way toward a more sustainable profession.
“Antimicrobial resistance is a critical One Health issue, and I look forward to continue working with colleagues across more than 2,500 clinics to support responsible antibiotic prescribing.
"Energy and interest in this area is growing profession-wide, demonstrating a reassuring recognition of how we can make meaningful improvements for people, pets, and the planet long into the future.”
Novartis Animal Health has launched a 0.5L pack of the anthelmintic Zolvix to make the product more readily available for quarantine dosing, and for the smaller sheep farmer.
Novartis says that because Zolvix is a broad spectrum anthelmintic that has the ability to kill all common sheep gastro-intestinal nematodes, including those resistant to existing treatments, it has a key role to play in quarantine treatment to keep parasite infection down to a minimum.
Simon Harris, Endoparasite Brand Manager at Novartis Animal Health, said: "As the first of the new generation of the Orange or 4-AD anthelmintic group, Zolvix has demonstrated effectiveness in killing worms, even those resistant to other products.
"Sheep farmers are being encouraged to use Zolvix as a quarantine treatment that can significantly reduce worm burdens on farm. I would stress that it is essential guidelines are followed in order to preserve Zolvix's ability to combat nematodes that have acquired resistance to other classes of wormers.
"This new pack size is aimed at farmers who are introducing new stock to their flocks, but will also be convenient for the smaller sheep farmer and smallholders who don't require such a large quantity of product."
Novartis says that because Zolvix is a short-acting anthelmintic, it does not encourage resistance to develop through a long duration of action. It has a high margin of safety so can be used to treat sheep and lambs including pregnant or lactating ewes and breeding rams. Its short meat withhold period of just seven days allows flexibility when marketing lambs.
Ceva Animal Health has launched Libeo, a new four-way break, palatable furosemide for the management of heart failure in dogs.
According to the company, furosemide - a diuretic - is the most frequently used treatment for the management of heart failure because it helps reduce pulmonary oedema and its quick onset of action is associated with a noticeable reduction in clinical signs.
However, Ceva highlights the fact that long-term under or over-dosing can have profound health implications for the patient, and says that current recommendations are to reduce the dose to the minimum effective dose as soon as the animal is stable and only increase it if required due to deterioration in heart function.
Ceva says that unlike other furosemides, Libeo has been designed solely for the veterinary market - specifically to facilitate easy and accurate dosing.
The four-way break tablet is available in a traditional 40mg tablet size as well as a unique 10mg size for small patients. The clover-shaped tablet is chicken-flavoured, designed to make it easier for owners to dose their pets and help improve long-term owner compliance. Each box of Libeo contains 120 blister-packed tablets, removing the need for someone to have to count out tablets.
Rob McLintock MRCVS, Companion Animal Business Unit Manager at Ceva Animal Health said: “87% of vets in the UK believe that the dose of furosemide given to pets by their owners is adversely affected by how difficult it is to split the tablets1. This is especially likely to affect pets whose owners are less dextrous or have difficulties using their hands. Libeo is both easy to administer and effective, thereby improving owner compliance and the long term health and welfare of their pets.”
The follow up service ‘can be provided personally by the veterinary surgeon or practice, or by written agreement with a veterinary services provider which is local to the client (as with the current situation for [out-of-hours] care provision)’.
The new rule comes into force on the 1st November, to allow practices to make any necessary arrangements.
The RCVS Council also decided that the temporary derogation from the usual requirement to conduct a physical examination before an animal is regarded as ‘under care’ be reviewed as a standing item at each subsequent Standards Committee meeting, until the normal guidance provisions are fully restored.
The group says it has led to 6,086 more clinical metrology questionnaires being conducted at participating practices with their patients, a 1,014% increase.
Developed by John Innes at the University of Liverpool, the Liverpool Osteoarthritis in Dogs (LOAD) questionnaire is a 13-item clinical metrology instrument (CMI) used to assess canine articular disorders like osteoarthritis.
It includes questions on the pets’ medical background, lifestyle and mobility.
Individual question scores are summed to provide an overall “LOAD score” suggestive of the animal’s disease presence and severity.
The questionnaire should be conducted every time the pet is presented to the veterinary clinic, with results tracked over time.
Treatment options - including the benefits and risks of all available modalities – can then be considered and discussed with owners to determine the best course of action, including weight management, diet, supplements, exercise and environmental modification, in addition to medication.
As part of the project, CVS provided a range of supporting resources for its practices, together with training.
Training focussed on diagnosing and managing conditions causing lameness in dogs and cats, using the clinical metrology questionnaire to engage clients in their pets’ treatment plan, offering best practice treatment options and running nurse mobility clinics.
It comprised of a vet CPD day run with Zoetis and the VOA on approach to and management of lame patients, two nurse CPD days on mobility clinics, a feline and canine orthopaedic examination video, First Opinion Clinical Club webinars on canine and feline osteoarthritis and an approach to radiographic interpretation course.
Resources included: new clinical guidelines, IMV resources (radiographic positioning, optimising the image and optimal chemical restraint) and a Mobility Clinic Booklet for clients.
Each site was then provided with its own data, so that they could monitor what they were doing individually.
One year after its nation-wide launch, results reveal that the number of clinical metrology questionnaires being conducted in the 35 participating practices has increased from 6 to 6,092 over a 12 month time period.
CVS says there was also evidence of an increasing incidence of the osteoarthritis drugs Librela and Solensia being prescribed.
Kathryn Patel, Hub Clinical Lead at CVS (pictured), who was responsible for the lameness clinical improvement project, said: “This project uses owner questionnaires to screen for and monitor the impact of lameness on patient quality of life and emphasises the importance of the whole clinical team in patient management.
"Vets and nurses will be supported to improve their ability to reach a diagnosis in every lame case, improve engagement with and compliance of owners with lame pets, and improve the quality of care of lame patients through appropriate medication, surgical intervention, and nurse and physiotherapy support.”
The RCVS Disciplinary Committee has directed that a Leeds-based veterinary surgeon, whose convictions for threatening behaviour, theft, and assault made him unfit to practise, should be removed from the Register.
At the outset of the two-day hearing, Dr Gary Samuel admitted his convictions. These related to his actions near his property in Cardiff on 10 July 2011, and were received at Cardiff Magistrates' Court on 22 November 2011. The Committee was asked to decide if these convictions made Dr Samuel unfit to practise veterinary surgery, and to decide upon any sanction.
The facts of the offences, as set out at the magistrates' court by the prosecution, were that Dr Samuel took a camera and memory card from a neighbour who was taking photographs of construction works behind his property. In doing so, he grabbed the neighbour from behind, twisting her arm, and later threatened her and her partner with a large piece of wood.
Although Dr Samuel wrote to the College saying he had pleaded guilty to the charges, he also denied some of the offences charged, suggesting that it was the neighbour who had been abusive towards him.
The Committee allowed the possibility that Dr Samuel was provoked by the taking of photographs and may have been subjected to offensive abuse by the neighbour, and considered that he acted impulsively and lost control of his actions. However, the convictions were for serious offences: the assault resulted in injury to the victim; the threatening behaviour involved a risk of injury to the victim and her partner; and, the theft involved dishonesty. Dr Samuel's conduct at the time was "reckless", and he had since displayed very limited insight into his behaviour.
Professor Peter Lees, chairing and speaking on behalf of the Committee said: "The Committee considers that the offences of which the Respondent was convicted, and to which he pleaded guilty, were serious, as is reflected in the suspended sentences, community service orders, fines, restrictions and penalties imposed by the court. The Committee accepts that this is not a case in which the welfare of animals has been put at risk, but takes the view that a serious sanction is required in order to uphold the reputation of the veterinary profession, and public confidence in it, and to uphold proper standards of conduct and behaviour on the part of its members."
The Committee directed Dr Samuel's name should be removed from the Register.
The BSAVA and Vets Now have signed a partnership agreement to develop a new postgraduate certificate in emergency and critical care (ECC).
The programme, which will follow the same broad structure as BSAVA's existing postgraduate certificate, will take its first group of students in May 2014.
Prof Michael Day, pictured above with Amanda Boag at BSAVA, said: "This is an exciting development to develop a qualification which will be relevant and accessible to vets in practice."
Amanda Boag added: "The combined expertise of both organisations will result in an engaging and high quality qualification in this field."
Vetsonic has taken over the marketing of Cavalesse, the oral nutritional supplement for horses that are prone to skin allergies, such as sweet itch.
Cavalesse contains a formulation of water-soluble vitamins and minerals, administered daily via a special pipette, either by sprinkling over a small handful of feed or adding to a treat. Vetsonic claims the supplement helps horses maintain a healthy skin and promotes normal immune function.
Ray Rochester, Managing Director of Vetsonic said: "It's an exciting phase in the development of Vetsonic which will see us rapidly expanding in the increasingly competitive small animal and equine market. Cavalesse is a welcome addition to our portfolio."
For further information, contact Vetsonic customer services on 01653 695333.